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IMMUNOLOGY AND INFLAMMATION

The aryl hydrocarbon receptor instructs the immunomodulatory
proﬁle of a subset of Clec4a4+ eosinophils unique to the
small intestine
Wei-Le Wanga,1 , Jun Kasamatsua,b,1, Satoru Joshitaa,c,1, Susan Gilfillana , Blanda Di Lucciaa, Santosh K. Pandaa, Do-Hyun Kima, Pritesh Desaid,
Jennifer K. Bandoa,e , Stanley Ching-Cheng Huanga,f, Kentaro Yomogidaa, Hitomi Hoshinog, Mana Fukushimag, Elizabeth A. Jacobsenh,
Steven J. Van Dykena , Christiane Ruedli , Marina Cellaa, and Marco Colonnaa,2
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C-type lectin domain family 4, member a4 (Clec4a4) is a C-type lectin inhibitory receptor speciﬁc for glycans thought to be exclusively expressed on murine CD8α2 conventional dendritic cells. Using newly generated Clec4a4-mCherry knock-in mice, we
identify a subset of Clec4a4-expressing eosinophils uniquely localized in the small intestine lamina propria. Clec4a4+ eosinophils evinced an immunomodulatory signature,
whereas Clec4a42 eosinophils manifested a proinﬂammatory proﬁle. Clec4a4+ eosinophils expressed high levels of aryl hydrocarbon receptor (Ahr), which drove the expression of Clec4a4 as well as other immunomodulatory features, such as PD-L1. The
abundance of Clec4a4+ eosinophils was dependent on dietary AHR ligands, increased
with aging, and declined in inﬂammatory conditions. Mice lacking AHR in eosinophils
expanded innate lymphoid cells of type 2 and cleared Nippostrongylus brasiliensis infection more effectively than did wild-type mice. These results highlight the heterogeneity
of eosinophils in response to tissue cues and identify a unique AHR-dependent subset
of eosinophils in the small intestine with an immunomodulatory proﬁle.

Signiﬁcance
Eosinophils contribute to type 2
immunity against helminths and
allergens. The small intestine
harbors eosinophils with
incompletely understood
pathophysiological roles. Here, we
show that intestinal eosinophils
include two subsets. One expresses
the inhibitory receptor Clec4a4 and
the inhibitory ligand PD-L1 and is
unique to the small intestine; the
other manifests a proinﬂammatory
phenotype. Both subsets are blood
derived. Remarkably, Clec4a4+
eosinophils were instructed by the
aryl hydrocarbon receptor (AHR), a
ligand-activated transcription factor
that imprints many gut immune
cells. Selective AHR deletion in
eosinophils depleted Clec4a4+
eosinophils, augmented innate
lymphocytes producing type 2
cytokines, and enhanced helminth
clearance. We conclude that
Clec4a4+ eosinophils have
immunomodulatory functions,
which could be harnessed for the
therapy of food allergies and
eosinophilic gastrointestinal
disorders.

eosinophil j intestine j helminth j aryl hydrocarbon receptor j allergy

Eosinophils are a small subset of granulocytes with acidophilic cytoplasmic granules that
are generated in the bone marrow (BM) from myeloid progenitors; circulate in the bloodstream; and reside at low numbers in hematopoietic organs, the lung, adipose tissue, and
the gastrointestinal tract (1–3). Eosinophil-speciﬁc granules contain cationic proteins, such
as major basic protein, eosinophil cationic protein, eosinophil-derived neurotoxin, and
eosinophil peroxidase (EPX), that have cytotoxic, ribonuclease, and oxidative activities
(3–5). Eosinophils also produce lipid mediators, such as cysteinyl leukotriene C4, which
activate cognate cysteinyl leukotriene receptors (CysLTRs) to promote vascular permeability, mucus secretion, and smooth muscle contraction (6). Moreover, eosinophils contain
intracellular granules that store preformed cytokines and chemokines, which enable these
leukocytes to respond to rapid stimuli and release soluble factors through classical exocytosis, piecemeal degranulation, and eosinophil cytolysis (7). Through this armamentarium of
soluble mediators, eosinophils primarily contribute to host defense against helminth infections. Inappropriate recruitment, accumulation, and activation of eosinophils are associated
with allergic inﬂammatory diseases, such as asthma, atopic dermatitis, and food allergy, as
well as primary eosinophilic gastrointestinal disorders. Signals that recruit and activate eosinophils during inﬂammation, such as eotaxins (CCL11, CCL24, CCL26), interleukins
(IL-5, IL-13, and IL-33), have been extensively investigated (8–11); however, little is
known about the signals that maintain tissue eosinophils quiescent in the steady state.
Clec4a4 (C-type lectin domain family 4, member a4; also known as DCIR2) is a
mouse cell surface receptor that belongs to the C-type lectin receptor (CLR) family
(12, 13). The carbohydrate recognition domain of Clec4a4 speciﬁcally binds to bisecting N-acetylglucosamine glycans expressed on normal cells (14). The cytoplasmic
domain of Clec4a4 contains an immunoreceptor tyrosine-based inhibition motif (15)
that recruits SHP protein tyrosine phosphatases, which mediate a downstream inhibitory pathway (16). Clec4a4 is the cell surface molecule recognized by the monoclonal
antibody 33D1 that deﬁnes CD8α conventional dendritic cells (cDCs) (17–21),
which specialize in antigen presentation by major histocompatibility complex (MHC)
class II to CD4+ T cells (17, 22). Clec4a4 deﬁciency was shown to enhance the ability
of CD8α cDCs to produce cytokines in response to toll-like receptor ligands and activate T and B cell immune responses against speciﬁc antigens (19).
Here, we generated a Clec4a4 reporter mouse and found that Clec4a4 is expressed
not only by CD8α cDCs but also by a subset of eosinophils that are uniquely present
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in the small intestine lamina propria (siLP), where they represent the largest eosinophil population. We demonstrated that
these Clec4a4+ eosinophils display a transcriptional proﬁle that
cumulatively denotes an immunomodulatory proﬁle, as it is
dominated by genes encoding inhibitory receptors, ligands
for inhibitory receptors expressed on other cells, leukotriene
degrading enzymes, and cholesterol biosynthetic enzymes. Conversely, the relatively minor population of Clec4a4– eosinophils
selectively displayed a phenotype prone to inﬂammation. Parabiosis demonstrated that both subsets are blood borne. The
gene expression program of Clec4a4+ eosinophils was in part
driven by the aryl hydrocarbon receptor (AHR), which induced
expression of Clec4a4 and other immunomodulatory molecules
while suppressing proinﬂammatory programs. The abundance
of Clec4a4+ eosinophils increased progressively with age and
depended on dietary AHR ligands, but it diminished in various
models of helminth infection and inﬂammation in parallel with
an increase of Clec4a4– eosinophils. Clec4a4 / mice, in which
both eosinophils and CD8α cDCs were freed from Clec4a4
inhibition, cleared Heligmosomoides polygyrus more efﬁciently
than did wild-type (WT) mice in early stages of the infection.
Moreover, EoCre × Ahr ﬂ/ﬂ mice, which selectively lack AHR
and AHR-induced genes (including Clec4a4) in eosinophils,
cleared Nippostrongylus brasiliensis infection more effectively
than control mice, perhaps due to increased expansion of unfettered type 2 innate lymphoid cells (ILC2s), which mediate
innate antihelminth responses (23, 24). We envision that AHR
and its dietary ligands imprint a subset of eosinophils residing
in the siLP with an immunomodulatory program. During parasitic infections and other pathogenic insults, changes in the tissue environment reverse the ratio between AHR-imprinted
eosinophils and eosinophils with an inﬂammatory program to
elicit an effective host response. This ﬁnding may open therapeutic avenues for reprogramming intestinal eosinophils in
food allergies as well as primary eosinophilic gastrointestinal
disorders of unknown etiology (25).
Results
+

2

The Small Intestine Contains Clec4a4 and Clec4a4 Eosinophil
Subsets. To identify Clec4a4-expressing cells, we generated

Clec4a4-mCherry knock-in (Clec4a4mCherry) mice (Fig. 1A). In
spleens of Clec4a4mCherry/+ mice, mCherry was selectively
expressed in CD11b+ dendritic cells (DCs) stained by the
33D1 monoclonal antibody, which recognizes Clec4a4 (17)
(Fig. 1B). This result veriﬁed that mCherry messenger RNA
was selectively transcribed under the control of the Clec4a4
promoter and recapitulated the expression pattern of Clec4a4
protein. We next surveyed mCherry expression in CD45+
hematopoietic cells from various tissues of Clec4a4mCherry/+
mice. A large number of mCherry+ CD45+ cells were observed
in the siLP (Fig. 1C). These cells encompassed two subsets with
distinct levels of CD11c expression (Fig. 1D). CD11chigh
mCherry+ cells expressed CD11b, CD103, and MHC class II
(Fig. 1E), thereby corresponding to the extensively characterized intestinal CD103+ CD11b+ cDCs (26). However, the
CD11clow mCherry+ subset expressed CD11b and SiglecF, a
cell surface marker of eosinophils, suggesting expression of
Clec4a4 on eosinophils. To corroborate this result, we examined mCherry expression in siLP eosinophils that were gated as
side scatter (SSC)high, MHC class II–, CD11b+, and SiglecF+
cells (27). Indeed, mCherry was expressed in ∼70 to 80% of
siLP eosinophils, whereas the mCherry– subset represented a
minor fraction (Fig. 1F and SI Appendix, Fig. S1A). Both
2 of 9
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mCherry+ and mCherry– eosinophils displayed ring-shaped
and segmented nuclei indicative of mature eosinophils (Fig.
1G). Both subsets expressed the CC chemokine receptor 3
(CCR3), a common eosinophil marker and a receptor for
eotaxin (Fig. 1H) (1–3). Analysis of intestinal sections of
Clec4a4mCherry/+ mice by ﬂuorescence microscopy at steady state
showed that most of the SiglecF+ Clec4a4+ eosinophils were
present in the lamina propria of the intestinal villi (Fig. 1I).
Examination of mCherry expression in eosinophils of colon,
adipose tissue, liver, lung, blood, and BM revealed that Clec4a4
expression was restricted to siLP eosinophils (Fig. 1J).
Since many immune cell types found in the small intestinal
mucosa consist of long-term tissue-resident cells adapted to
environmental cues, we sought to examine whether this is the
case for Clec4a4+ eosinophils. We performed parabiosis, joining WT (CD45.1) and Clec4a4mCherry/+ (CD45.2) mice for
6 wk. Analysis of CD45.1 WT mice revealed a substantial proportion of CD45.2+ eosinophils in the small intestine (Fig. 1 K
and L), ∼60% of which were mCherry+ (Fig. 1M), suggesting
that Clec4a4+ eosinophils are mainly blood borne rather than
derived from a local resident population. Interestingly, although
the frequency of parabiont-derived eosinophils in the small
intestine was similar to that observed in blood and lung, only
cells in the small intestine expressed mCherry, indicating that
Clec4a4 is induced by the unique environment of the small
intestine. Accordingly, mCherry was not expressed in activated
lung eosinophils puriﬁed from a model of house dust
mite–induced inﬂammation (SI Appendix, Fig. S1B). Within
the small intestine, the representation of Clec4a4+ eosinophils
varied in different segments, decreasing from the proximal to
most distal regions (SI Appendix, Fig. S1C). Taken together, these
results demonstrate that the small intestine contains Clec4a4+ and
Clec4a4 eosinophil subsets in the steady state and that the
Clec4a4+ subset is unique to the small intestine due to the impact
of the microenvironment on blood-derived eosinophils.
Clec4a4+ and Clec4a42 Eosinophils Display Distinct Receptor
Repertoires. To gain more insight into the characteristics of

Clec4a4+ eosinophils, we examined genes differentially
expressed between ﬂuorescence-activated cell sorting (FACS)sorted Clec4a4+ and Clec4a4 eosinophils by microarray analysis (the sorting strategy is shown in SI Appendix, Fig. S1A).
Seventy-four transcripts were expressed at least twofold higher in
Clec4a4+ eosinophils than in the Clec4a4 population, whereas
85 transcripts had the opposite pattern (Fig. 2 A and B and SI
Appendix, Fig. S2 A and B). Clec4a4+ eosinophils abundantly
expressed Cd22, Cd68, Pecam1, and Cd274 (encoding PD-L1),
whereas Itgb7 (encoding the β7-integrin) was more highly
expressed by Clec4a4 eosinophils. We conﬁrmed by ﬂow cytometry that a fraction of siLP Clec4a4+ eosinophils expressed CD22,
a receptor of the sialoadhesin family that transmits inhibitory signals; all Clec4a4+ eosinophils expressed the lysosomal marker
CD68, the adhesion molecule PECAM1, and CD274 (PD-L1),
which is the ligand for the inhibitory receptor PD-1 (Fig. 2C).
Conversely, Clec4a4 eosinophils expressed the lymphocyte
Peyer’s patch adhesion molecule 1 (LPAM1), which consists of
the α4β7-integrin heterodimer. A survey of these cell surface
markers in the eosinophils of colon lamina propria, adipose tissue,
liver, lung, blood, and BM showed that CD22 was exclusively
expressed in siLP eosinophils, corroborating a recent study (28)
(Fig. 2D); CD68 was expressed by blood eosinophils, and
PECAM1 was expressed by liver, lung, blood, and BM eosinophils. LPAM1 was expressed in all Clec4a4 eosinophils of various tissues. Overall, these data validate the identiﬁcation of two
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Fig. 1. A heterogeneous population of Clec4a4+ and Clec4a4 eosinophils resides in the small intestine. (A) Targeting strategy to generate Clec4a4mCherry/+
mice. CDS, coding sequence; H2B, human histone H2B; T2A, T2A self-cleaving peptide; UTR, untranslated region. (B) Expression of Clec4a4 and mCherry in
splenic CD11b+ cDCs. (C) Frequency of mCherry+ cells among CD45+ cells (gated on live cells) in the indicated tissues (n = 3 to 7). DLN, skin-draining lymph
node; LP, lamina propria; MLN, mesenteric lymph node. (D) mCherry expression on CD11chigh and CD11clow CD45+ cells derived from siLP (gated on live
cells). (E) Expression of CD11b, CD103, Siglec-F, and MHC class II on mCherry+ CD11chigh CD45+ cells and mCherry+ CD11clow CD45+ cells derived from siLP
(gated on live cells). (F) mCherry expression in Siglec-F+ eosinophils derived from siLP (gated on SSChigh MHC class II CD11b+ cells). (G) Representative pictures of FACS-sorted mCherry+ and mCherry eosinophils from siLP. (H) CCR3 expression in mCherry+ and mCherry eosinophils in siLP. (I) Representative image
showing localization of Siglec-F+mCherry+ eosinophils in siLP villi of Clec4a4mCherry/+ mice. Inset is an enlargement of I. DAPI, 40 ,6-diamidino-2-phenylindole.
(J) mCherry expression in eosinophils in the indicated tissues. (K) Parabiosis of CD45.1 WT and CD45.2 Clec4a4mCherry/+ mice indicates that eosinophils recirculate
in siLP, blood, and lung but much less so in BM; Clec4A4 mCherry is only expressed by eosinophils in the siLP. (L) Frequency of parabiont-derived eosinophils in
the indicated tissues. (M) Frequency of parabiont-derived mCherry+ eosinophils in the indicated tissues. Results are shown as mean ± SEM. P values were calculated using one-way ANOVA and the Tukey's multiple comparisons test or the two-tailed Student’s t test. ns, not signiﬁcant. ***P < 0.001; ****P < 0.0001.

phenotypically distinguishable subsets of siLP eosinophils. The
lung was recently reported to include a subset of SiglecFintCD62L+CD101low–resident eosinophils and a subset of
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Siglec-FhiCD62LCD101hi–recruited inﬂammatory eosinophils
(29). However, these subsets were phenotypically distinct from
Clec4a4+ and Clec4a4 siLP subsets, as both CD62L and
https://doi.org/10.1073/pnas.2204557119
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Fig. 2. Transcriptomic proﬁling and characterization of Clec4a4+ and Clec4a4 eosinophil subsets. (A) Volcano plot of differentially expressed genes in
mCherry+ and mCherry eosinophils (n = 5 replicates in each group). Transcripts with FC (fold change) > 2 and P < 0.05 in mCherry+ and mCherry eosinophils are depicted in red and blue, respectively. (B) Heat map of selected genes speciﬁc to Clec4a4+ and Clec4a4 eosinophils. (C) Differential expression of
cell surface (CD22, PECAM1, PD-L1, and LPAM1) and intracellular markers (CD68) by Clec4a4+ and Clec4a4 siLP eosinophils. (D) Expression of the markers
indicated in C by eosinophils from the indicated tissues. LP, lamina propria. (E, Left) Expression of Clec4a4 and PD-L1 in eosinophils derived from siLP.
(E, Right) Frequency of Clec4a4+PD-L1+ and Clec4a4PD-L1lo eosinophils in the siLP. (F) Enrichment plots demonstrating up-regulated cholesterol homeostasis and
TNFα signaling via NF-κB in mCherry+ and mCherry eosinophils, respectively. NES, normalized enrichment score; FDR, false discovery rate. (G) Biochemical pathways for de novo cholesterol synthesis. CoA, coenzyme A; HMG, hydroxymethylglutaryl. (H) Heat map of genes associated with cholesterol synthesis pathways in
mCherry+ and mCherry eosinophils. Results are shown as mean ± SEM. P values were calculated using the two-tailed Student’s t test. **P < 0.01.
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CD101 were weakly expressed in siLP eosinophils (SI Appendix,
Fig. S2C).
We noted that Clec4a4+ eosinophils expressed higher
amounts of signal-regulatory protein alpha (SIRPα) (SI
Appendix, Fig. S2D), a receptor that delivers intracellular inhibitory signals upon recognition of its ubiquitously expressed
ligand CD47 (30, 31). Given that CD22 and Clec4a4 have
also been shown to be potent inhibitory receptors speciﬁc for
glycans expressed by B cells (32) and DCs (19), respectively,
the concerted expression of these inhibitory receptors suggests
that Clec4a4+ eosinophils are fairly refractory to activating
stimuli. Notably, Clec4a4+ eosinophils expressed PD-L1 (Fig.
2 C–E), which inhibits ILC2, T cells, and myeloid cells expressing PD-1 (33, 34). Thus, Clec4a4+ eosinophils may further
maintain a noninﬂammatory environment by inhibiting
immune responses by ILC2s, T cells, and myeloid cells. Conversely, the Clec4a4– subset expressed LPAM1, which interacts
with mucosal cell adhesion molecule-1 expressed in vascular endothelium and is required for the homing of eosinophils into the
gastrointestinal tract (2), suggesting that Clec4a4– eosinophils may
be recently recruited from the blood.
Clec4a4+ and Clec4a42 Eosinophils Express Alternative
Immunomodulatory and Inflammatory Programs. We next

explored transcriptome proﬁles of Clec4a4+ and Clec4a4
eosinophils for different functional properties. Clec4a4+ eosinophils selectively expressed Dipeptidase 2 (Dpep2), a membranebound dipeptidase that hydrolyses the leukotriene D4 into
leukotriene E4 (Fig. 2A and SI Appendix, Fig. S2 A and B).
LTE4 is the weakest activator of CysLTR1 (6), and DPEP2 has
been reported to modulate macrophage inﬂammation and
nuclear factor kappa B (NF-κB) signaling independent of its
enzymatic activity (35). Another striking feature of the
Clec4a4+ eosinophil transcriptome was the concerted expression of many genes controlling the de novo cholesterol biosynthesis pathway (e.g., Hmgcs1, Pvmk, Idi1, Fdps, Fdft1, Sqle,
Sc5d, Cyp51, Sc4mol) (36) (Fig. 2 F–H). Cholesterol synthesis
may be necessary to generate membranes for efﬁcient intracellular storage of eosinophil granules and for secretory vesicles (7).
Clec4a4 eosinophils evinced a clear proinﬂammatory and tissue repair proﬁle exempliﬁed by the preferential expression of
genes involved in inﬂammation (S100a8, S100a9, Tnf, Il6) and
ﬁbrosis (Oncostatin M, Osm) (Fig. 2A and SI Appendix, Fig. S2 A
and B). The expression of Irak3, components of the NF-κB pathway (e.g., Nfkb1, Nfkb2, Nfkbia), Fas, and components of the
inﬂammasome (e.g., Nlrp3, Casp4) corroborated the proinﬂammatory predisposition of Clec4a4 eosinophils (Fig. 2F and SI
Appendix, Fig. S2E). A similar gene expression pattern was
observed in BM eosinophils stimulated by IL-33, which activates
the NF-κB pathway (37). Overall, these results demonstrate that
Clec4a4+ and Clec4a4– siLP eosinophilic subsets have distinct
immunomodulatory and proinﬂammatory programs, respectively.
AHR Drives the Profile of Clec4a4+ Eosinophils.

We asked
which transcription factors could drive the different programs
of siLP eosinophils. We noted that Clec4a4+ eosinophils preferentially expressed the Ahr gene and its target Cyp1b1, which
we conﬁrmed by qRT-PCR analysis (Fig. 3 A and B). AHR is a
member of the Per–Arnt–Sim superfamily of transcription factors that sense environmental signals. In the gut, AHR senses
indole compounds that are generated by degradation of nutritional tryptophan by the microbiota or are directly introduced
with certain foods, such as cruciferous vegetables (38–42).
AHR signaling sustains development and function of many cell
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types in the intestine, including ILC3s, Th17, DCs, macrophages, intraepithelial lymphocytes (IELs), and enteric neurons
(41–45). To validate the impact of AHR on Clec4a4+ eosinophils, we examined Ahr/ mice. Ahr/ siLP eosinophils and
DCs did not express Clec4a4, while Ahr/ spleen CD11b+
cDCs maintained Clec4a4 (Fig. 3C and SI Appendix, Fig. S3A).
We also noted that the absence of Clec4a4+ eosinophils in Ahr/
mice was paralleled by a compensatory increase in Clec4a4– eosinophils, such that the total number of eosinophils was comparable
in Ahr/ and WT mice (Fig. 3D). Thus, AHR is required for
Clec4a4 expression, while the overall pool of siLP eosinophils is
AHR independent in the steady state. To see whether the requirement of AHR was cell intrinsic or cell extrinsic, we performed a
mixed BM chimera experiment. After lethal irradiation, CD45.1+
WT mice were transplanted with a 50:50 mixture of CD45.1/2+
WT BM and CD45.2+ Ahr/ BM (Fig. 3E). Both WT BM and
Ahr/ BM successfully reconstituted splenocytes (SI Appendix,
Fig. S3B) and spleen CD11b+ Clec4a4+ cDCs (Fig. 3 F and G)
in about a 50:50 WT/Ahr/ ratio (Fig. 3 F and G). Small intestinal eosinophils were reconstituted at a 30:70 WT/Ahr/ ratio (SI
Appendix, Fig. S3B), indicating that Ahr/ eosinophils have a
competitive reconstitution advantage over WT eosinophils for reasons that remain to be determined. Notwithstanding, only WT
BM reconstituted both Clec4a4+ and Clec4a4– eosinophils,
whereas Ahr/ BM could only generate Clec4a4– eosinophils
(Fig. 3 F and G). We conclude that the requirement of AHR for
Clec4a4 expression in eosinophils is cell intrinsic.
We next asked whether AHR is just required for Clec4a4
expression or for the differentiation of the entire Clec4a4+ eosinophil program. Since all eosinophils were Clec4a4– in Ahr/
mice, we selected genes differentially expressed between Clec4a4+
and Clec4a4– eosinophils of WT mice and ascertained their
expression in Clec4a4– eosinophils of Ahr/ mice. Among the
genes more abundantly expressed in WT Clec4a4+ than in WT
Clec4a4– eosinophils, 20 genes, including Cd22, were more
highly expressed in Clec4a4 eosinophils of Ahr/ mice than in
Clec4a4 eosinophils of WT mice, indicating AHR independency (SI Appendix, Fig. S3C). Conversely, 21 of the genes highly
expressed in WT Clec4a4+ but not in WT Clec4a4– eosinophils
were expressed at low levels in Clec4a4 eosinophils of Ahr/
mice, indicating AHR dependency; these genes included Dpep2
as well as genes involved in cholesterol metabolism, including
Idi1, Sc5d, Hmgcs1, and Hsd17b7 (SI Appendix, Fig. S3C).
Among the genes expressed less in WT Clec4a4+ than in WT
Clec4a4– eosinophils, 17 genes were expressed at higher levels in
Ahr/ eosinophils, indicating suppression by AHR (SI Appendix,
Fig. S3D). These genes included many inﬂammatory molecules,
such as Il6, S100a8, and S100a9. In comparison with their relatively high expression in Clec4a4 eosinophils of WT mice, 10
genes were equally suppressed in Clec4a4+ eosinophils of WT
mice and Clec4a4 eosinophils of Ahr/ mice, including Tnf,
Nlrp3, and Fas (SI Appendix, Fig. S3D). Taken together, these
results demonstrate that the differentiation of Clec4a4+ eosinophils is both AHR dependent and independent. Genes either
induced or suppressed in an AHR-independent fashion in
Clec4a4+ eosinophils may be controlled by other transcription
factors, such as NR4A2 (also called Nurr1), which is more abundantly expressed in Clec4a4+ than in Clec4a4– eosinophils (SI
Appendix, Fig. S3C) and has been shown to control inﬂammation
and lipid metabolism (46).
Differentiation of Clec4a4+ Eosinophils Is Partly Dependent
on Dietary AHR Ligands. Since AHR senses indole compounds

generated by intestinal microbiota or introduced with certain
https://doi.org/10.1073/pnas.2204557119
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Fig. 3. Development of the Clec4a4+ eosinophil subset is dependent on aging and on the AHR pathway. (A) Heat map of Ahr and Cyp1b1 in mCherry+ and
mCherry eosinophils. (B) qRT-PCR of Ahr and Cyp1b1 transcripts in Clec4a4+ and Clec4a4 eosinophils (n = 4 replicates). (C) Clec4a4 expression in splenic
CD11b+ cDCs and siLP eosinophils from WT and Ahr/ mice. (D) Absolute numbers of Clec4a4+ and Clec4a4 eosinophils in WT and Ahr/ mice (n = 3 in
each group). (E) Experimental strategy for mixed BM chimeras. (F) Clec4a4 expression in splenic CD11b+ cDCs and siLP eosinophils derived from WT and
Ahr/ BM cells after reconstitution. (G) Frequency of Clec4a4+ and Clec4a4 splenic CD11b+ cDCs and siLP eosinophils in BM chimeras. (H) Frequency of
Clec4a4+ and Clec4a4 siLP eosinophils in WT mice at 1, 2, and 10 to 12 wk of age (n = 3, 6, and 7 replicates, respectively) and in GF mice (n = 5). (I) Experimental time line for feeding mice with a puriﬁed diet free of AHR ligands or a puriﬁed diet containing the AHR ligand I3C. (J) Representative Clec4a4 expression in siLP eosinophils derived from mice fed with a puriﬁed diet free of AHR ligands or a puriﬁed diet containing AHR ligands. (K) Frequency of Clec4a4+
and Clec4a4 siLP eosinophils in mice fed with a puriﬁed diet free of AHR ligands (n = 4) or a puriﬁed diet containing AHR ligands (n = 5). Results are shown
as mean ± SEM. P values were calculated using the two-tailed Student’s t test. NS, not signiﬁcant. *P < 0.05; ***P < 0.001.
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eosinophils were more abundant in young adult mice than in
1- or 2-wk-old mice (Fig. 3H). To directly test the impact of
microbiota on siLP eosinophils, we examined germ-free (GF)
mice but found that Clec4a4+ eosinophils were equally
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represented in GF and control speciﬁc pathogen–free (SPF)
mice (Fig. 3H). We also treated SPF mice with antibiotics and
then, colonized them with Lactobacilluls reuteri 100-23, which
produces large amounts of indole ligands when fed a
tryptophan-rich diet (44, 47). However, enrichment of microbiota with indole-producing L. reuteri did not expand Clec4a4+
eosinophils further than that seen in mice colonized with an
L. reuteri mutant unable to produce AHR ligands (SI Appendix,
Fig. S3E). We hypothesized that the lack of bacterial-derived
AHR ligands may be compensated by dietary ligands. To test
the impact of dietary AHR ligands, weaned mice were fed a
puriﬁed diet lacking AHR ligands for 4 wk and then, kept for
an additional 4 wk on this diet with or without additional
indole-3-carbinol (I3C), a plant-derived precursor of AHR ligands
(Fig. 3I). The population of Clec4a4+ eosinophils declined in
mice fed the puriﬁed diet but was restored by the I3C supplement
(Fig. 3 J and K), corroborating a dependency of Clec4a4+ eosinophils on nutritional AHR ligands.
Clec4a4+ Eosinophils Wane during Intestinal Inflammation.

We sought to assess the presence of Clec4a4+ and Clec4a4–
eosinophils in response to infection with H. polygyrus, a natural
intestinal parasite of mice (48). In this experimental model,
BALB/c mice are infected with H. polygyrus by oral gavage with
infective larvae, which penetrate into the submucosa of the
small intestine and develop into adult worms that return into
the intestinal lumen, mate, and produce eggs that are excreted
in the feces. We noted that after infection with H. polygyrus,
Clec4a4+ eosinophils declined by day 8 postinfection, whereas
Clec4a4 eosinophils expanded in compensation (SI Appendix,
Fig. S4A). A similar decrease of Clec4a4+ eosinophils paralleled
by a compensatory increase of Clec4a4 eosinophils was
observed in other intestinal inﬂammatory conditions, such as
those induced in a model of high-fat diet (SI Appendix, Fig.
S4B) and in a model of food allergy caused by gastrointestinal
intolerance to ovalbumin (SI Appendix, Fig. S4 C–F). These
ﬁndings raise the possibility that Clec4a4+ eosinophils become
Clec4a4 in pathological settings, acquiring a proinﬂammatory
program more suitable for host responses. In addition, newly
recruited Clec4a4 eosinophils may fail to acquire the AHRinduced proﬁle.
Clec4a4 and AHR Imprinting Attenuate Host Defense against
Parasites. Given that Clec4a4 is an inhibitory receptor, we

hypothesized that a deletion of Clec4a4 may augment the early
responses against parasites, such as H. polygyrus. To test this, we
infected homozygous Clec4a4mCherry/mCherry mice, in which both
endogenous Clec4a4 genes are disrupted by mCherry. Mice were
infected with H. polygyrus and examined for the numbers of
eggs in the feces on days 10, 12, 14, 16, and 18 postinfection.
Clec4a4mCherry/mCherry mice had lower egg counts than did WT
mice on days 12 and 14 postinfection (Fig. 4A), suggesting that
the release of quiescent eosinophils from Clec4a4-mediated inhibition enhances early host responses against helminth infection.
Since Clec4a4 is expressed in both eosinophils and CD11b+
DCs, both of which may contribute to host response, we
sought to more selectively establish the impact of Clec4a4 and
possibly, other AHR-induced genes on the clearance of helminth infection. For this purpose, we crossed mice with ﬂoxed
alleles of Ahr (Ahr ﬂ/ﬂ) with an EoCre deleter mice, in which Cre
recombinase is driven by the endogenous promoter of Epx (49).
A marked reduction of Clec4a4+ eosinophils was evident in the
small intestine of EoCre × Ahr ﬂ/ﬂ mice (Fig. 4B). This ﬁnding
was consistent with the cell-intrinsic requirement of AHR for
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Clec4a4 expression observed in the mixed BM chimera experiment (Fig. 3F). The expression of PD-L1 on small intestine
eosinophils was also markedly reduced in EoCre × Ahr ﬂ/ﬂ mice
(Fig. 4 B and C). We next challenged EoCre × Ahr ﬂ/ﬂ mice with
H. polygyrus. Fecal content of H. polygyrus eggs and granuloma
counts were similar in EoCre × Ahrﬂ/ﬂ mice and control mice
(SI Appendix, Fig. S5). We further infected mice with N. brasiliensis, which elicits a more rapid gastrointestinal expulsion
than H. polygyrus. While clearance of H. polygyrus infection in
C57BL/6 mice requires up to 20 wk and a sustained T cell
response (50), adult N. brasiliensis worms are normally expelled
from the intestines of C57BL/6 mice by day 7 postinfection.
N. brasiliensis counts were lower in EoCre × Ahrﬂ/ﬂ mice than in
control mice on day 6 postinfection (Fig. 4D). We noted that
enhanced worm expulsion was paralleled by an increase in
ILC2s in mesenteric lymph nodes (Fig. 4 E and F). ILC2s
mediate antiparasitic responses through secretion of IL-5 and
IL-13 (23, 24). Since ILC2s express the inhibitory receptor
PD-1 (34) and Clec4a4+ eosinophils express PD-L1, the lack
of this inhibitory interaction in EoCre × Ahrﬂ/ﬂ mice may facilitate
ILC2 expansion. We conclude that AHR-imprinted Clec4a4+
eosinophils attenuate intestinal parasite clearance mechanisms.
Discussion
Eosinophils contribute to host defense against helminth infections through the release of granule proteins, leukotrienes, and
cytokines but can also cause allergic inﬂammation (1–3). Using
a newly generated reporter mouse for the inhibitory receptor
Clec4a4, we have identiﬁed a unique population of eosinophils
exclusively found in the siLP. In addition to Clec4a4, the
receptor repertoire of these cells included other inhibitory
receptors, such as CD22 (28) and SIRPα (30, 31). The concomitant expression of PD-L1, which inhibits ILC2s, T cells, and
myeloid cells expressing PD-1, and DPEP2, which degrades leukotrienes, indicates that Clec4a4+ eosinophils may be both refractory to activation and prone to restrain intestinal immune
responses. This large population of Clec4a4+ eosinophils was
accompanied by a smaller population of Clec4a4– eosinophils
with a proinﬂammatory and tissue repair program specifying
tumor necrosis factor (TNF), IL-6, and OSM among other soluble mediators. These cells were poorly represented in the steady
state but expanded in inﬂammatory conditions, while Clec4a4+
eosinophils declined. Gut Clec4a4+ and Clec4a4– eosinophils
were phenotypically distinct from other eosinophil subsets recently
reported in the lung, such as lung-resident eosinophils (29) and
airway-recruited inﬂammatory eosinophils (29). We conclude that
eosinophils, like other immune cell types, exhibit a tissue diversity
that reﬂects the inﬂuence of microenvironmental factors.
Remarkably, the phenotype of Clec4a4+ eosinophils was in
part instructed by AHR, which also controls the development
and function of many other gut immune cell populations,
including ILC3s, Th17, DCs, macrophages, and IELs, as well
as enteric neurons (41–45). AHR drove expression of Clec4a4
as well as other immunomodulatory molecules, such as DPEP2
and PD-L1. A very recent study independently corroborated
that eosinophils of the gastrointestinal tract display an AHRdependent proﬁle (51). In the gut, AHR is activated by indoles
derived from vegetables that contain tryptophan catabolic products (38–42) and microbial degradation of nutritional tryptophan (47). Accordingly, Clec4a4+ eosinophils were depleted in
mice fed an AHR ligand–deprived diet but restored by a supplement of nutritional I3C; although not formally conﬁrmed
by us, I3C is known to generate the biologically active AHR
https://doi.org/10.1073/pnas.2204557119
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Fig. 4. Clec4a4+ eosinophils modulate type 2 immunity during helminth infection. (A) Egg counts in feces of WT and Clec4a4-deﬁcient (Clec4a4mCherry/mCherry)
mice (n = 13 in each group) at the indicated time points during H. polygyrus infection. (B) Expression of Clec4a4 and PD-L1 in siLP eosinophils derived from
Ahrﬂ/+ and EoCreAhrﬂ/ﬂ mice. (C) Frequency of Clec4a4+PD-L1+ and Clec4a4PD-L1lo siLP eosinophils in Ahrﬂ/+ and EoCreAhrﬂ/ﬂ mice (n = 3 each group). (D)
Worm counts in Ahrﬂ/ﬂ (n = 12) and EoCreAhrﬂ/ﬂ (n = 15) mice at day 6 postinfection with N. brasiliensis. (E) Representative percentages of KLRG1+ ILC2s among
CD45+ cells in mesenteric lymph nodes (MLNs) of Ahrﬂ/ﬂ and EoCreAhrﬂ/ﬂ mice. A gate was applied on lineage-negative cells. Lineage markers included CD3,
CD4, CD8, CD19, and NK1.1. (F) Frequency of ILC2s in MLNs from Ahrﬂ/ﬂ (n = 12) and EoCreAhrﬂ/ﬂ (n = 14) mice at day 6 postinfection with N. brasiliensis.
Results are shown as mean ± SEM. P values were calculated using the two-tailed Student’s t test or one-way ANOVA and the Tukey's multiple comparisons
test. NS, not signiﬁcant. *P < 0.05; ***P < 0.001.

ligand indolo[3,2-b]carbazole in the acidic pH of the stomach.
Clec4a4+ eosinophils were similarly represented in GF mice
and SPF mice; moreover, this population did not preferentially
expand in mice with a microbiota enriched with AHR
ligand–producing bacteria, suggesting redundancy between dietary
and microbiota-generated AHR ligands. Future studies will be
necessary to test the relative impact of dietary and microbiotaderived AHR ligands in the generation of Clec4a4+ eosinophils
by comparing the abundance of these cells in GF and SPF mice
fed a puriﬁed diet and reconstituted with microbes either competent or unable to produce AHR ligands.
The instruction of Clec4a4+ eosinophils by AHR ligands is
reminiscent of the tissue imprinting previously reported in gutresident immune cells, such as ILCs and macrophages. However,
our parabiosis experiment demonstrated that Clec4a4+ eosinophils
are blood derived, while tissue-resident ILCs and macrophages are
long-lived tissue cells that renew from local progenitors (52–54).
We conclude that blood eosinophils adapt to the environment
and acquire Clec4a4+ features soon after reaching the small intestine. Notably, during intestinal H. polygyrus infection or models of
inﬂammation, the representation of Clec4a4+ eosinophils rapidly
declined, paralleled by an increase of Clec4a4– eosinophils. We
envision that Clec4a4+ eosinophils derive from blood Clec4a4–
eosinophils instructed by AHR signaling. In inﬂammatory conditions, this imprinting may weaken or vanish because of decreased
AHR expression or less accessible AHR ligands in the altered tissue
environment. Further studies are needed to test this hypothesis.
We noted that the functional impact of AHR-imprinted eosinophils in antihelminth defense was different in the two models
of helminth infection in EoCre × Ahr ﬂ/ﬂ mice that we tested.
Clearance of H. polygyrus infection was similar in EoCre × Ahr ﬂ/ﬂ
and control mice, a result that was also recently reported (51).
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Since H. polygyrus infection lasts up to 20 wk in B6 mice and
requires a robust Th2 response for worm clearance, this result probably reﬂects the limited contribution of eosinophils to this infection
model (55, 56). Conversely, N. brasiliensis was more effectively
cleared in EoCre × Ahr ﬂ/ﬂ mice. This phenotype correlated with an
increased frequency of ILC2s in the mesenteric lymph nodes,
which may reﬂect release of PD-1+ ILC2s from the inhibitory constraints imposed by PD-L1 expressed on eosinophils (34). Whether
Th2 responses are also altered in this scenario remains to be established. We envision that the immunomodulatory effect of AHRdependent eosinophils may preferentially emerge in this model
because N. brasiliensis infection in C57BL/6 mice elicits a more
rapid and robust gastrointestinal immune response in which eosinophils may play a more prominent role (57).
To date, human counterparts of gut Clec4a4+ and Clec4a4–
eosinophils have not been identiﬁed. In the mouse, Clec4a4 is one
of four closely linked CLR genes, Clec4a1 to -4 (also known as
Dcir1 to -4); in humans, only one DCIR molecule exists, which is
expressed by CD14+ monocytes, CD15+ granulocytes, DC subsets, and B cells in the peripheral blood (15, 58–60). Thus, more
eosinophil-speciﬁc markers should be investigated. The identiﬁcation of an AHR-imprinted eosinophil subset in human intestine
may open therapeutic avenues aimed at reprogramming eosinophils in food allergies and primary eosinophilic gastrointestinal disorders that are caused by abnormal eosinophil activation (25).
Materials and Methods
Experimental details on animals, cell extraction from tissues, antibody staining
for ﬂow cytometry and sorting, microarray analyses, parasitic infections, and statistical analyses for this study are described in detail in SI Appendix, Materials
and Methods.
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Data Availability. Microarray data reported in this paper have been deposited
in Gene Expression Omnibus (accession no. GSE199370). All study data are
included in the article and/or SI Appendix.
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